The Only Health Care Prices That Matter to Consumers June 25, 2019 Perspective In this column, Drew Altman zeroes in on a key test for when the implementing rules are written for the new executive order on hospital price transparency: consumers will need to know what amount they must pay out of pocket to really help them shop on price.
Why Doctors and Nurses Can Be Vital Vaccine Messengers April 5, 2021 Perspective In this Axios column, Drew Altman examines why doctors and nurses are such critical messengers in the effort to build vaccine confidence.
Where To Start To Build Vaccine Confidence March 22, 2021 Perspective In this Axios column Drew Altman writes about the recent attention to Republican vaccine resisters. “Republicans and rural Americans are among the most resistant vaccine holdouts and some strategies are emerging to reach them.” But “far from all Republicans are resisters” and “the bigger and quicker payoff will come from prioritizing the more moveable group of ‘wait and see’ Americans.”
Vaccine Confidence Isn’t The Main Obstacle To Reaching Herd Immunity March 1, 2021 Perspective In this Axios column, Drew Altman paints a more optimistic picture of the prospects for getting to herd immunity as vaccine confidence grows, but underscores the urgency of building vaccine confidence in Black and Latino communities where barriers to access and good information are obstacles to getting vaccinated.
Seeing Others Vaccinated May Be The Best Cure For Vaccine Hesitancy February 10, 2021 Perspective In his latest Axios column, Drew Altman shows why vaccine hesitancy will naturally decrease as more and more people see their family members and friends vaccinated without adverse consequences. It’s a hopeful sign about vaccine hesitancy, and should help free up resources to focus on the remaining vaccine hesitant.
Addressing the Risk of Medicare Trust Fund Insolvency January 27, 2021 Perspective In this Viewpoint for the Journal of the American Medical Association (JAMA), KFF’s Tricia Neuman and co-author Richard G. Frank of Harvard Medical School explain that the looming 2024 insolvency of the Medicare Hospital Insurance Trust Fund cannot be ignored for long.
How Quickly We Need To Ramp Up Vaccinations To Get To Herd Immunity January 26, 2021 Perspective Debate about how many vaccinations are needed by when has been in the news. Drew Altman lays it out in his latest column.
The Challenge Of Vaccine Hesitancy In Rural America January 12, 2021 Perspective In his latest Axios column, Drew Altman looks at the challenge of vaccine hesitancy in rural America and its implications. One of them: a highly tailored outreach campaign is needed. “Addressing this hesitancy will require convincing rural Americans about the seriousness of the pandemic, and then that the vaccine is a way to protect them, their families and their way of life,” he said.
Real Progress Is Possible On Vaccine Hesitancy December 15, 2020 Perspective Drew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.
It May Be Time To Waive Patients’ Costs for Coronavirus Treatment March 19, 2020 Perspective Drew Altman looks at the numbers for COVID-19 treatment, and why it may soon be necessary for Congress to waive out-of-pocket costs for treatment.
